Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-05-30

Clinical Trial Update: Post Kidney Transplant Nocturnal Hypertension Prevalence and Management Study [NA]

View source ↗

Summary

The trial evaluating nocturnal hypertension in kidney transplant recipients was withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Northwell Health | Conditions: Hypertension | NA | Status: WITHDRAWN